Gannett Stands By $815M Tribune Bid, Despite Poison Pill
Gannett Co. Inc. plans to press on with its $815 million hostile bid for Tribune Publishing Co., despite the company's recent adoption of a poison pill, on Friday reiterating its calls...To view the full article, register now.
Already a subscriber? Click here to view full article